5 pending office actions • 4 art units • 5 examiners • 0 of 5 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 5 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 5 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 2 (40%) |
| §103 only | 1 (20%) |
| No statute on record | 2 (40%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| WENG, PEI YONG | 1 | 79.5% | +23.0% |
| KONOPELSKI SNAVEL, SARA ELIZABETH | 1 | 33.3% | +30.0% |
| ZEMAN, MARY K | 1 | 59.0% | +34.5% |
| WOITACH, JOSEPH T | 1 | 49.1% | +27.5% |
| KRIANGCHAIVECH, KETTIP | 1 | 20.8% | +32.8% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17339598 | ARTIFICIAL INTELLIGENCE ENGINE ARCHITECTURE FOR GENERATING CANDIDATE DRUGS | WOITACH, JOSEPH T | 25d overdue |
| 17319839 | GENERATING ANTI-INFECTIVE DESIGN SPACES FOR SELECTING DRUG CANDIDATES | KRIANGCHAIVECH, KETTIP | 4d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18638784 | GENERATING ENHANCED GRAPHICAL USER INTERFACES FOR PRESENTATION OF ANTI-INFECTIVE DESIGN SPACES FOR SELECTING DRUG CANDIDATES | WENG, PEI YONG | 111d overdue |
| 17403194 | ARTIFICIAL INTELLIGENCE ENGINE FOR GENERATING CANDIDATE DRUGS USING EXPERIMENTAL VALIDATION AND PEPTIDE DRUG OPTIMIZATION | ZEMAN, MARY K | 45d overdue |
| 17339598 | ARTIFICIAL INTELLIGENCE ENGINE ARCHITECTURE FOR GENERATING CANDIDATE DRUGS | WOITACH, JOSEPH T | 25d overdue |
| 17319839 | GENERATING ANTI-INFECTIVE DESIGN SPACES FOR SELECTING DRUG CANDIDATES | KRIANGCHAIVECH, KETTIP | 4d overdue |
| 18447414 | INTRAVENOUS ADMINISTRATION OF ENGINEERED ANTIMICROBIAL AMPHIPHILIC PEPTIDES | KONOPELSKI SNAVEL, SARA ELIZABETH | 29d |
| Art Unit | Apps |
|---|---|
| 1686 | 2 |
| 2141 | 1 |
| 1658 | 1 |
| 1687 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18638784 | GENERATING ENHANCED GRAPHICAL USER INTERFACES FOR PRESENTATION OF ANTI-INFECTIVE DESIGN SPACES FOR SELECTING DRUG CANDIDATES | WENG, PEI YONG | 2141 | Other | Non-Final OA | 111d overdue | Pending | Apr 18, 2024 |
| 18447414 | INTRAVENOUS ADMINISTRATION OF ENGINEERED ANTIMICROBIAL AMPHIPHILIC PEPTIDES | KONOPELSKI SNAVEL, SARA ELIZABETH | 1658 | Other | Non-Final OA | 29d | Pending | Aug 10, 2023 |
| 17403194 | ARTIFICIAL INTELLIGENCE ENGINE FOR GENERATING CANDIDATE DRUGS USING EXPERIMENTAL VALIDATION AND PEPTIDE DRUG OPTIMIZATION | ZEMAN, MARY K | 1686 | §103 | Final Rejection | 45d overdue | Pending | Aug 16, 2021 |
| 17339598 | ARTIFICIAL INTELLIGENCE ENGINE ARCHITECTURE FOR GENERATING CANDIDATE DRUGS | WOITACH, JOSEPH T | 1687 | §101 | Non-Final OA | 25d overdue | Pending | Jun 04, 2021 |
| 17319839 | GENERATING ANTI-INFECTIVE DESIGN SPACES FOR SELECTING DRUG CANDIDATES | KRIANGCHAIVECH, KETTIP | 1686 | §101 | Non-Final OA | 4d overdue | Pending | May 13, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial